SonoVascular, Inc.
Mohamed Lahlou is an accomplished engineer with extensive experience in biomedical engineering and embedded software development. Currently serving as a Principal Engineer at SonoVascular, Inc. since January 2024, Lahlou previously held the position of Lead Biomedical Engineer at SoundPipe Therapeutics, where responsibilities included solving design challenges for catheter-based ultrasound systems and conducting R&D testing. Lahlou began career as a Biomedical Engineer, generating ultrasound specifications and deploying therapy systems, and also served as an Embedded Medical Device Software Engineer, programming FPGA and developing software for medical devices. Prior experience includes a role as an Embedded Software Engineer at AutoMedx and an Electrician at KhanElec. Lahlou holds a Bachelor’s Degree in Bioengineering and Biomedical Engineering from George Mason University.
This person is not in any teams
SonoVascular, Inc.
SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system, SonoThrombectomy™, that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to remove blood clots more effectively. The system uniquely combines: (i) ultrasound, (ii) microbubbles, (iii) low dose thrombolytic drug, and (iv) mechanical retrieval and aspiration, delivered via an integrated intravascular catheter system. SonoVascular’s technology has been engineered to address and overcome the deficiencies and limitations of current interventional devices. Its design enables safe and effective treatment in the catheterization laboratory (cathlab), maximizes the reduction in clot burden, enhances the delivery and reduces the dose and duration of thrombolytics to levels that optimize safety and effectiveness, and eliminates the need for patients to be treated in the ICU.